Barrington Research Reiterates Outperform on HealthEquity, Maintains $85 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Alexander Paris has reiterated an Outperform rating on HealthEquity (NASDAQ:HQY) and maintained a price target of $85.
December 04, 2023 | 5:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barrington Research reaffirms HealthEquity with an Outperform rating and a price target of $85, indicating a positive outlook on the stock.
The reiteration of an Outperform rating by a research analyst typically signals confidence in the company's future performance. Maintaining a price target of $85 suggests that the analyst believes the stock has the potential to rise to that level, which could positively influence investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100